Articles & Publications

We are dedicated to contributing novel research across all our areas of expertise. Please search our research below to explore our published work.

ABHI UK HealthTech Conference Round-up

ABHI UK HealthTech Conference Round-up

  • ABHI UK HealthTech Conference
  • Nov 2023
What is the Cost of Increased Flexibility in Reimbursement Decision-Making?

What is the Cost of Increased Flexibility in Reimbursement Decision-Making?

  • Westminster Health Forum
  • Feb 2023
When Does “Access” Become “Established” in Rare Diseases?

When Does “Access” Become “Established” in Rare Diseases?

  • ISPOR 2021 EU
  • Jan 2023
Balancing Earlier Access and Data Immaturity – Are New Methods the Key?

Balancing Earlier Access and Data Immaturity – Are New Methods the Key?

  • ISPOR 2021 EU
  • Jan 2023
Costello Medical ISPOR Europe 2022 Report

Costello Medical ISPOR Europe 2022 Report

  • ISPOR Europe 2022
  • Dec 2022
Costello Medical ISMPP EU Report 2022

Costello Medical ISMPP EU Report 2022

  • ISMPP 2022 EU
  • Nov 2022
Costello Medical ISPOR APAC 2022 Report

Costello Medical ISPOR APAC 2022 Report

  • ISPOR APAC 2022
  • Sep 2022
When Does a Treatment Effect Really Stop? Exploration of Different Methods for Modelling Treatment Waning

When Does a Treatment Effect Really Stop? Exploration of Different Methods for Modelling Treatment Waning

  • ISPOR Washington 2022
  • Sep 2022
Adoption of Piecewise Modelling: A Review of NICE Health Technology Appraisals in Oncology

Adoption of Piecewise Modelling: A Review of NICE Health Technology Appraisals in Oncology

  • ISPOR Washington 2022
  • Sep 2022
Healthcare Resource Use of People who use Illicit Opioids in England: A Retrospective Cohort Study Using Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES)

Healthcare Resource Use of People who use Illicit Opioids in England: A Retrospective Cohort Study Using Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES)

  • ISPOR Virtual Europe 2021
  • Sep 2022
Capturing The Value Of Potentially Curative Oncology Therapies: Lessons From The Use And Acceptance Of Cure Modelling Assumptions In NICE Technology Appraisals

Capturing The Value Of Potentially Curative Oncology Therapies: Lessons From The Use And Acceptance Of Cure Modelling Assumptions In NICE Technology Appraisals

  • ISPOR Virtual Europe 2021
  • Sep 2022
Accuracy of Life Year Gains Predictions for CAR-T Therapy in the Long Term: An Analysis for AxicabtageneCiloleucelin Refractory Large B-Cell Lymphoma

Accuracy of Life Year Gains Predictions for CAR-T Therapy in the Long Term: An Analysis for AxicabtageneCiloleucelin Refractory Large B-Cell Lymphoma

  • ISPOR Virtual Europe 2021
  • Sep 2022
Orphan Drug Compassionate Use Programmes: Impact on Reimbursement Decisions in France, Germany and England

Orphan Drug Compassionate Use Programmes: Impact on Reimbursement Decisions in France, Germany and England

  • ISPOR Virtual Europe 2021
  • Sep 2022
When Does a Treatment Effect Really Stop? Exploration of Different Methods for Modelling Treatment Waning

When Does a Treatment Effect Really Stop? Exploration of Different Methods for Modelling Treatment Waning

  • ISPOR US 2022
  • Jun 2022
Adoption of Piecewise Modelling: A Review of NICE Health Technology Appraisals in Oncology

Adoption of Piecewise Modelling: A Review of NICE Health Technology Appraisals in Oncology

  • ISPOR US 2022
  • Jun 2022
Costello Medical AMCP 2022 Report

Costello Medical AMCP 2022 Report

  • AMCP 2022 Report
  • Apr 2022
Costello Medical ISPOR US Report 2021

Costello Medical ISPOR US Report 2021

  • ISPOR US 2021
  • Jul 2021
Costello Medical ISMPP EU Report 2021

Costello Medical ISMPP EU Report 2021

  • ISMPP 2021 EU
  • Mar 2021
Investigating Potential Market Failure with Curative Cell and Gene Therapies

Investigating Potential Market Failure with Curative Cell and Gene Therapies

  • ISPOR Milan 2020
  • Feb 2021
Orphan Drug Compassionate Use Programmes: Scale of Use and Association with Regulatory and Reimbursement Decisions in France, Germany and the UK

Orphan Drug Compassionate Use Programmes: Scale of Use and Association with Regulatory and Reimbursement Decisions in France, Germany and the UK

  • ISPOR Milan 2020
  • Feb 2021
Probabilistic Cost-Effectiveness Results and Managed Access Agreements: A Review of Therapies Entering the Cancer Drugs Fund in England

Probabilistic Cost-Effectiveness Results and Managed Access Agreements: A Review of Therapies Entering the Cancer Drugs Fund in England

  • ISPOR Milan 2020
  • Feb 2021
Approaches to the Collection of Utility Values for Rare Diseases: A Cross-Country Comparison

Approaches to the Collection of Utility Values for Rare Diseases: A Cross-Country Comparison

  • ISPOR Milan 2020
  • Feb 2021
Costello Medical ISPOR Annual Meeting Report 2020

Costello Medical ISPOR Annual Meeting Report 2020

  • ISPOR US 2020
  • Jun 2020
Costello Medical ISMPP EU Report 2020

Costello Medical ISMPP EU Report 2020

  • ISMPP 2020 EU
  • Mar 2020
Trends in Patient-Focused Presentations at Scientific Congresses: A European Rheumatology Congress Case Study

Trends in Patient-Focused Presentations at Scientific Congresses: A European Rheumatology Congress Case Study

  • ISMPP EU 2020
  • Jan 2020
Geographic Differences in the Growth of Open Access Publishing

Geographic Differences in the Growth of Open Access Publishing

  • ISMPP 2020 London
  • Jan 2020
Costello Medical ISPOR Copenhagen Report 2019

Costello Medical ISPOR Copenhagen Report 2019

  • ISPOR 2019 Copenhagen
  • Dec 2019
Approaches to the Collection of Utility Values for Rare Diseases

Approaches to the Collection of Utility Values for Rare Diseases

  • ISPOR Copenhagen 2019
  • Nov 2019
Impact of Generics and Biosimilars on Branded Drug Listing Decisions in Singapore

Impact of Generics and Biosimilars on Branded Drug Listing Decisions in Singapore

  • ISPOR 2019 Copenhagen
  • Nov 2019
Development, Validation and Concordance of Clinical Code Sets Used in Real-World Database Studies

Development, Validation and Concordance of Clinical Code Sets Used in Real-World Database Studies

  • ISPOR 2019 Copenhagen
  • Nov 2019
To What Extent Does Seeking Clinical Expert Opinion for Model Inputs Reduce the Cost of Uncertainty? A Conceptual Approach Using Expected Value of Perfect Parameter Information (EVPPI)

To What Extent Does Seeking Clinical Expert Opinion for Model Inputs Reduce the Cost of Uncertainty? A Conceptual Approach Using Expected Value of Perfect Parameter Information (EVPPI)

  • ISPOR 2019 Copenhagen
  • Nov 2019
Trust the Experts? Acceptance of Expert Elicitation in the National Institute for Health and Care Excellence (NICE) Single Technology Appraisal (STA) Process

Trust the Experts? Acceptance of Expert Elicitation in the National Institute for Health and Care Excellence (NICE) Single Technology Appraisal (STA) Process

  • ISPOR 2019 Copenhagen
  • Nov 2019
Parallel Scientific Advice from NICE and CADTH: Would One Submission Fit All?

Parallel Scientific Advice from NICE and CADTH: Would One Submission Fit All?

  • ISPOR 2019 Copenhagen
  • Nov 2019
Accurate Predictions of Life Year Gains for Immuno-Oncology Therapies in the Long Term? An Analysis Based on Published Checkmate 057 Nivolumab Data

Accurate Predictions of Life Year Gains for Immuno-Oncology Therapies in the Long Term? An Analysis Based on Published Checkmate 057 Nivolumab Data

  • ISPOR 2019 Copenhagen
  • Nov 2019
Real-World Evidence in Gene Therapies: Recommendations Versus Reality

Real-World Evidence in Gene Therapies: Recommendations Versus Reality

  • ISPOR 2019 Copenhagen
  • Nov 2019
A Formal System for Using Real-World Evidence to Revisit the HTA Decision: More Trouble Than It’s Worth?

A Formal System for Using Real-World Evidence to Revisit the HTA Decision: More Trouble Than It’s Worth?

  • ISPOR 2019 Copenhagen
  • Nov 2019
Is Delayed Access Due to Issues of HTA Capacity a Necessary Reality or an Unacceptable Problem?

Is Delayed Access Due to Issues of HTA Capacity a Necessary Reality or an Unacceptable Problem?

  • ISPOR 2019 Copenhagen
  • Nov 2019
Costello Medical ISMPP Asia-Pacific 2019 Report

Costello Medical ISMPP Asia-Pacific 2019 Report

  • ISMPP 2019 Asia-Pacific
  • Nov 2019
Systematic Literature Review and Network Meta-analysis of Sodium-glucose Co-transporter Inhibitors vs Metformin as Add-on to Insulin in Type 1 Diabetes

Systematic Literature Review and Network Meta-analysis of Sodium-glucose Co-transporter Inhibitors vs Metformin as Add-on to Insulin in Type 1 Diabetes

  • Online Article
  • Aug 2019
Associations Between Comorbidities and Adverse Events of Antiepileptic Drugs and Quality of Life: A Survey of Epilepsy Patients in Australia

Associations Between Comorbidities and Adverse Events of Antiepileptic Drugs and Quality of Life: A Survey of Epilepsy Patients in Australia

  • Online Article
  • Jul 2019
Associations Between Cognitive and Memory Problems, Employment and Quality of Life: A Survey of Epilepsy Patients in Australia

Associations Between Cognitive and Memory Problems, Employment and Quality of Life: A Survey of Epilepsy Patients in Australia

  • Online Article
  • Jul 2019
Costello Medical ISPOR US Report 2019

Costello Medical ISPOR US Report 2019

  • ISPOR 2019 New Orleans
  • Jul 2019
Real-world Anti-viral Treatment Decisions Among Chronic Hepatitis C Patients in Taiwan: The INITIATE Study

Real-world Anti-viral Treatment Decisions Among Chronic Hepatitis C Patients in Taiwan: The INITIATE Study

  • Online Article
  • Jun 2019
Influencing ICER: A Review of Manufacturer Involvement in ICER Assessments

Influencing ICER: A Review of Manufacturer Involvement in ICER Assessments

  • ISPOR 2019 New Orleans
  • Jun 2019
Real-World Evidence on the Rise: Evaluating the Use of Real-World Evidence in ICER Assessments of Comparative Clinical Effectiveness

Real-World Evidence on the Rise: Evaluating the Use of Real-World Evidence in ICER Assessments of Comparative Clinical Effectiveness

  • ISPOR 2019 New Orleans
  • May 2019
Patient, Payer and Manufacturer Perspectives on Four Cost-Control Mechanisms for Pharmaceuticals

Patient, Payer and Manufacturer Perspectives on Four Cost-Control Mechanisms for Pharmaceuticals

  • ISPOR 2019 New Orleans
  • May 2019
Bundled Payments for Care Improvement Advanced (BPCI-A): An Analysis of Public Communications During the Application Period

Bundled Payments for Care Improvement Advanced (BPCI-A): An Analysis of Public Communications During the Application Period

  • ISPOR 2019 New Orleans
  • May 2019
What’s Trending? Pharmacoeconomic Publications in the US between 2009–2018

What’s Trending? Pharmacoeconomic Publications in the US between 2009–2018

  • ISPOR 2019 New Orleans
  • May 2019
Framework Synthesis (FS) of Qualitative and Quantitative Evidence to Explore the Differential Diagnosis (DDx) of Diarrhea in Neuroendocrine Tumor (NET) Patients

Framework Synthesis (FS) of Qualitative and Quantitative Evidence to Explore the Differential Diagnosis (DDx) of Diarrhea in Neuroendocrine Tumor (NET) Patients

  • ISPOR 2019 New Orleans
  • May 2019
Expansion of State Medicaid Programs: Increased Patient Access to Opioid Replacement Therapy?

Expansion of State Medicaid Programs: Increased Patient Access to Opioid Replacement Therapy?

  • ISPOR 2019 New Orleans
  • May 2019
Vax-The-Nation: A Budget Impact Analysis of Costs Associated with Measles Outbreaks in the USA Through Increasing Measles, Mumps and Rubella Vaccination Uptake

Vax-The-Nation: A Budget Impact Analysis of Costs Associated with Measles Outbreaks in the USA Through Increasing Measles, Mumps and Rubella Vaccination Uptake

  • ISPOR 2019 New Orleans
  • May 2019
Thinking Ahead: The Evolution of Scientific Communication

Thinking Ahead: The Evolution of Scientific Communication

  • ISMPP EU 2019 Report
  • Mar 2019
How do Patients and Caregivers Access Scientific Literature?

How do Patients and Caregivers Access Scientific Literature?

  • ISMPP EU 2019
  • Feb 2019
Are Results from Human Factors Studies Communicated Consistently and Transparently?

Are Results from Human Factors Studies Communicated Consistently and Transparently?

  • ISMPP EU 2019
  • Feb 2019
Defining ‘White Paper’ Publications in the Peer-Reviewed Medical Literature

Defining ‘White Paper’ Publications in the Peer-Reviewed Medical Literature

  • ISMPP EU 2019
  • Feb 2019
Who’s Who in Rare Diseases: A Case Study in Author Identification

Who’s Who in Rare Diseases: A Case Study in Author Identification

  • ISMPP EU 2019
  • Feb 2019
Modelling the Impact and Cost-Effectiveness of Extended Screening and Treatment with Direct-Acting Antivirals in a Swiss Custodial Setting

Modelling the Impact and Cost-Effectiveness of Extended Screening and Treatment with Direct-Acting Antivirals in a Swiss Custodial Setting

  • Online Article
  • Feb 2019
Costello Medical ISPOR Barcelona Report 2018

Costello Medical ISPOR Barcelona Report 2018

  • ISPOR 2018 Barcelona
  • Dec 2018
Real World Data and Real World Evidence in Singapore: Are We Ready?

Real World Data and Real World Evidence in Singapore: Are We Ready?

  • ISPOR Singapore Regional Chapter
  • Nov 2018
Evidence Development Timeline of Medical Devices in the UK: Where do MedTech Innovation Briefings Fit?

Evidence Development Timeline of Medical Devices in the UK: Where do MedTech Innovation Briefings Fit?

  • ISPOR 2018 Barcelona
  • Nov 2018
Exploring the Use and Acceptance of Alternative Survival Modelling Approaches for Immuno-Oncology Therapies in UK Technology Assessments

Exploring the Use and Acceptance of Alternative Survival Modelling Approaches for Immuno-Oncology Therapies in UK Technology Assessments

  • ISPOR 2018 Barcelona
  • Nov 2018
Determining Factors for Decision-Making in the Medical Technologies Evaluation Programme

Determining Factors for Decision-Making in the Medical Technologies Evaluation Programme

  • ISPOR 2018 Barcelona
  • Nov 2018
Improving Patient and Financial Outcomes in the NHS: Early Arthritis Service Increases Patient Satisfaction Whilst Saving Costs

Improving Patient and Financial Outcomes in the NHS: Early Arthritis Service Increases Patient Satisfaction Whilst Saving Costs

  • ISPOR 2018 Barcelona
  • Nov 2018
Health Technology Assessment of mHealth Applications: Slow Progress in a Fast-Paced Industry?

Health Technology Assessment of mHealth Applications: Slow Progress in a Fast-Paced Industry?

  • ISPOR 2018 Barcelona
  • Nov 2018
Medical Device Appraisal in the UK: What Are the Common Pitfalls of Manufacturer Literature Reviews?

Medical Device Appraisal in the UK: What Are the Common Pitfalls of Manufacturer Literature Reviews?

  • ISPOR 2018 Barcelona
  • Nov 2018
Comorbidities, Concomitant Medications and Potential Drug‐drug Interactions with Interferon‐free Direct‐acting Antiviral Agents in Hepatitis C Patients in Taiwan

Comorbidities, Concomitant Medications and Potential Drug‐drug Interactions with Interferon‐free Direct‐acting Antiviral Agents in Hepatitis C Patients in Taiwan

  • Online Article
  • Oct 2018
Increasing hepatitis C virus screening in people who inject drugs in Switzerland using rapid antibody saliva and dried blood spot testing: A cost‐effectiveness analysis

Increasing hepatitis C virus screening in people who inject drugs in Switzerland using rapid antibody saliva and dried blood spot testing: A cost‐effectiveness analysis

  • Online Article
  • Oct 2018
Health state utility values measured using the EuroQol 5-dimensions questionnaire in adults with chronic hepatitis C: a systematic literature review and meta-analysis

Health state utility values measured using the EuroQol 5-dimensions questionnaire in adults with chronic hepatitis C: a systematic literature review and meta-analysis

  • Online Article
  • Sep 2018
Focused Ultrasound Thalamotomy and Other Interventions for Medication-Refractory Essential Tremor: An Indirect Comparison of Short-Term Impact on Health-Related Quality of Life

Focused Ultrasound Thalamotomy and Other Interventions for Medication-Refractory Essential Tremor: An Indirect Comparison of Short-Term Impact on Health-Related Quality of Life

  • Online Article
  • Jun 2018
Systematic Review of the Clinical Efficacy of Vaginal Progesterone for Luteal Phase Support in Assisted Reproductive Technology Cycles

Systematic Review of the Clinical Efficacy of Vaginal Progesterone for Luteal Phase Support in Assisted Reproductive Technology Cycles

  • Online Article
  • Jun 2018
Ask the Internet: Analysis of Online Discussions of Value Frameworks

Ask the Internet: Analysis of Online Discussions of Value Frameworks

  • HTAi 2017 Rome
  • Jun 2018
Hot Topics from the European Conference on Rare Diseases and Orphan Products 2018

Hot Topics from the European Conference on Rare Diseases and Orphan Products 2018

  • Published on LinkedIn
  • May 2018
Alkaptonuria Severity Score Index Revisited: Analysing the AKUSSI and Its Subcomponent Features

Alkaptonuria Severity Score Index Revisited: Analysing the AKUSSI and Its Subcomponent Features

  • Online Article
  • Apr 2018
Medical Affairs Leaders Forum 2018: Costello Medical’s Roundup

Medical Affairs Leaders Forum 2018: Costello Medical’s Roundup

  • Published on LinkedIn
  • Apr 2018
Release of First Medical Device HTA Guidance in Singapore

Release of First Medical Device HTA Guidance in Singapore

  • Published on LinkedIn
  • Apr 2018
Costello Medical’s Attendance at the Findacure Drug Repurposing for Rare Diseases Conference 2018

Costello Medical’s Attendance at the Findacure Drug Repurposing for Rare Diseases Conference 2018

  • Published on LinkedIn
  • Apr 2018
NICE Consultation on Proposed Changes to the Technology Appraisal Programme Phase 2

NICE Consultation on Proposed Changes to the Technology Appraisal Programme Phase 2

  • Feb 2018
Costello Medical’s Attendance at SMi’s Orphan Drugs and Rare Diseases Conference

Costello Medical’s Attendance at SMi’s Orphan Drugs and Rare Diseases Conference

  • Published on LinkedIn
  • Feb 2018
ISMPP European Meeting, London 2018

ISMPP European Meeting, London 2018

  • Feb 2018
Evidence in Support of Hyperkalaemia Management Strategies: A Systematic Literature Review

Evidence in Support of Hyperkalaemia Management Strategies: A Systematic Literature Review

  • Online Article
  • Feb 2018
Costello Medical’s MedTech Conference Roundup

Costello Medical’s MedTech Conference Roundup

  • Published on LinkedIn
  • Jan 2018
Buzzwords in Highly-Cited Manuscript Abstracts

Buzzwords in Highly-Cited Manuscript Abstracts

  • ISMPP 2018 London
  • Jan 2018
Rare Disease Publications: How Accessible Are They?

Rare Disease Publications: How Accessible Are They?

  • ISMPP 2018 London
  • Jan 2018
Reporting of Delphi Methods to Achieve Consensus on Guidelines in Rare Diseases

Reporting of Delphi Methods to Achieve Consensus on Guidelines in Rare Diseases

  • ISMPP 2018 London
  • Jan 2018
Long-Term Retention Rates for Anti-Epileptic Drugs: A Review of Long-Term Extension Studies and Comparison with Brivaracetam

Long-Term Retention Rates for Anti-Epileptic Drugs: A Review of Long-Term Extension Studies and Comparison with Brivaracetam

  • Online Article
  • Dec 2017
ISPOR 20th Annual European Congress, Glasgow 2017

ISPOR 20th Annual European Congress, Glasgow 2017

  • Dec 2017
Evaluating Matching-Adjusted Indirect Comparison and Simulated Treatment Comparison Techniques: Impact on HRQoL of Focussed Ultrasound Thalamotomy and Other Interventions for the Treatment of Medication-Refractory Essential Tremor

Evaluating Matching-Adjusted Indirect Comparison and Simulated Treatment Comparison Techniques: Impact on HRQoL of Focussed Ultrasound Thalamotomy and Other Interventions for the Treatment of Medication-Refractory Essential Tremor

  • ISPOR 2017 Glasgow
  • Nov 2017
No EQ-5D? Analysis of Alternative Utility Value Sources Used in NICE Appraisals for Oncology Indications

No EQ-5D? Analysis of Alternative Utility Value Sources Used in NICE Appraisals for Oncology Indications

  • ISPOR 2017 Glasgow
  • Nov 2017
Consumer Comments in Health Technology Assessment in Australia: How Common and Influential Are They?

Consumer Comments in Health Technology Assessment in Australia: How Common and Influential Are They?

  • ISPOR 2017 Glasgow
  • Nov 2017
Health Technology Assessment in Singapore: Shining a Light in the Darkness

Health Technology Assessment in Singapore: Shining a Light in the Darkness

  • ISPOR 2017 Glasgow
  • Nov 2017
How Do NICE Evidence Review Groups Perceive Single Technology Appraisals Presenting Limited Evidence of Comparative Treatment Efficacy?

How Do NICE Evidence Review Groups Perceive Single Technology Appraisals Presenting Limited Evidence of Comparative Treatment Efficacy?

  • ISPOR 2017 Glasgow
  • Nov 2017
When the Price Is Right: When, in Practice, Are Confidential Discounts Introduced in the NICE Process?

When the Price Is Right: When, in Practice, Are Confidential Discounts Introduced in the NICE Process?

  • ISPOR 2017 Glasgow
  • Nov 2017
An Audit of Evidence Review Group Criticisms of Systematic Literature Reviews Conducted to Inform Manufacturers’ Submissions to the National Institute for Health and Care Excellence

An Audit of Evidence Review Group Criticisms of Systematic Literature Reviews Conducted to Inform Manufacturers’ Submissions to the National Institute for Health and Care Excellence

  • ISPOR 2017 Glasgow
  • Nov 2017
Payers, Politics and Pandemonium: An Insight into the Future UK Pricing and Market Access Environment

Payers, Politics and Pandemonium: An Insight into the Future UK Pricing and Market Access Environment

  • ISPOR 2017 Glasgow
  • Nov 2017
Does the NICE Diagnostics Assessment Programme Use an Empirical ICER Threshold?

Does the NICE Diagnostics Assessment Programme Use an Empirical ICER Threshold?

  • ISPOR 2017 Glasgow
  • Nov 2017
Model Types Submitted to NICE: What Is Considered Appropriate by Evidence Review Groups?

Model Types Submitted to NICE: What Is Considered Appropriate by Evidence Review Groups?

  • ISPOR 2017 Glasgow
  • Nov 2017
An Exploration of the Methodology of Published Systematic Literature Reviews on “Burden of Disease”

An Exploration of the Methodology of Published Systematic Literature Reviews on “Burden of Disease”

  • ISPOR 2017 Glasgow
  • Nov 2017
Why do ‘True’ Orphan Medicines Have Such a Low Acceptance Rate When Assessed by the SMC?

Why do ‘True’ Orphan Medicines Have Such a Low Acceptance Rate When Assessed by the SMC?

  • ISPOR 2017 Glasgow
  • Nov 2017
Exploring Concurrent Validity of The CLN2 Clinical Rating Scale: Comparison To PedsQL Using Mixed Effects Modelling And Data From A Phase 1/2 Single-Arm Trial

Exploring Concurrent Validity of The CLN2 Clinical Rating Scale: Comparison To PedsQL Using Mixed Effects Modelling And Data From A Phase 1/2 Single-Arm Trial

  • ISPOR 2017 Glasgow
  • Nov 2017
Challenges Associated with Estimating Utility in Wet Age-Related Macular Degeneration: A Novel Regression Analysis to Capture the Bilateral Nature of the Disease

Challenges Associated with Estimating Utility in Wet Age-Related Macular Degeneration: A Novel Regression Analysis to Capture the Bilateral Nature of the Disease

  • Online Article
  • Oct 2017
Screening for Vasa Praevia in the Second Trimester of Pregnancy: External Review Against Programme Appraisal Criteria for the UK National Screening Committee (UK NSC)

Screening for Vasa Praevia in the Second Trimester of Pregnancy: External Review Against Programme Appraisal Criteria for the UK National Screening Committee (UK NSC)

  • Online Article
  • Jun 2017
Costs and Effectiveness of Fingolimod Versus Alemtuzumab in the Treatment of Highly Active Relapsing-Remitting Multiple Sclerosis in the UK: Re-Treatment, Discount, and Disutility

Costs and Effectiveness of Fingolimod Versus Alemtuzumab in the Treatment of Highly Active Relapsing-Remitting Multiple Sclerosis in the UK: Re-Treatment, Discount, and Disutility

  • Online Article
  • Jun 2017
HTAi 14th Annual Meeting, Rome 2017

HTAi 14th Annual Meeting, Rome 2017

  • Jun 2017
Inequity in Healthcare Access in Asian Countries with Reportedly High Universal Health Coverage Levels

Inequity in Healthcare Access in Asian Countries with Reportedly High Universal Health Coverage Levels

  • HTAi 2017 Rome
  • Jun 2017
Cost-Effectiveness of PET-CT Versus Adrenal Vein Sampling for the Diagnosis of Hypertension Caused by Primary Aldosteronism

Cost-Effectiveness of PET-CT Versus Adrenal Vein Sampling for the Diagnosis of Hypertension Caused by Primary Aldosteronism

  • HTAi 2017 Rome
  • Jun 2017
ISMPP 13th Annual International Meeting, Washington 2017

ISMPP 13th Annual International Meeting, Washington 2017

  • May 2017
NICE Annual Conference, London 2017

NICE Annual Conference, London 2017

  • May 2017
ISPOR 22nd Annual International Congress, Boston 2017

ISPOR 22nd Annual International Congress, Boston 2017

  • May 2017
Value Frameworks to Set Tongues Wagging: Analysis of Opinions and Discussions on Key Value Frameworks

Value Frameworks to Set Tongues Wagging: Analysis of Opinions and Discussions on Key Value Frameworks

  • ISPOR 2017 Boston
  • May 2017
Cost-Effectiveness of PET-CT Versus Adrenal Vein Sampling for the Diagnosis of Hypertension Caused by Primary Aldosteronism

Cost-Effectiveness of PET-CT Versus Adrenal Vein Sampling for the Diagnosis of Hypertension Caused by Primary Aldosteronism

  • ISPOR 2017 Boston
  • May 2017
Small and Medium-Sized Enterprises: How Do They Fare in the UK Medical Technologies Evaluation Programme (MTEP)?

Small and Medium-Sized Enterprises: How Do They Fare in the UK Medical Technologies Evaluation Programme (MTEP)?

  • ISPOR 2017 Boston
  • May 2017
Inequity in Healthcare Access in Asian Countries with Reportedly High Universal Health Coverage Levels

Inequity in Healthcare Access in Asian Countries with Reportedly High Universal Health Coverage Levels

  • ISPOR 2017 Boston
  • May 2017
Maximising Research Impact: Is Less More?

Maximising Research Impact: Is Less More?

  • ISMPP 2017 London
  • Jan 2017
ISMPP European Meeting, London 2017

ISMPP European Meeting, London 2017

  • Jan 2017
The Prevalence and Characteristics of Lay Summaries of Published Journal Articles

The Prevalence and Characteristics of Lay Summaries of Published Journal Articles

  • ISMPP 2017 London
  • Jan 2017
The Role of Scientific Interns as Medical Publication Professionals

The Role of Scientific Interns as Medical Publication Professionals

  • ISMPP 2017 London
  • Jan 2017
Using Augmented Reality for Congress Posters: Challenges and Considerations

Using Augmented Reality for Congress Posters: Challenges and Considerations

  • ISMPP 2017 London
  • Jan 2017
The Impact of Hepatitis C Virus Outside the Liver: Evidence from Asia

The Impact of Hepatitis C Virus Outside the Liver: Evidence from Asia

  • Online Article
  • Nov 2016
Pharmacological Interventions for Familial Hypercholesterolaemia in Children and Adolescents: An Exploratory Evaluation Using Advanced Hierarchical Network Meta-Analysis Techniques

Pharmacological Interventions for Familial Hypercholesterolaemia in Children and Adolescents: An Exploratory Evaluation Using Advanced Hierarchical Network Meta-Analysis Techniques

  • Online Article
  • Nov 2016
Risk of All-Cause Mortality in Alcohol-Dependent Individuals: A Systematic Literature Review and Meta-Analysis.

Risk of All-Cause Mortality in Alcohol-Dependent Individuals: A Systematic Literature Review and Meta-Analysis.

  • Online Article
  • Sep 2015
Loading